|
"shan ys"的相关文件
显示项目 31-80 / 133 (共3页)
1 2 3 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2022-07 |
A phase II trial of nivolumab, gemcitabine and S-1 as the frst-line treatment in patients with biliary tract cancer
|
Chen, MH;Chiang, NJ;Bai, LY;Huang, CJ;Chen, SC;Hsiao, CF;Shan, YS;Su, YY;Chen, LT |
| 國家衛生研究院 |
2022-06-26 |
The differential clinical impacts of cachexia and sarcopenia on the prognosis of advanced pancreatic cancer
|
Hou, YC;Chen, CY;Huang, CJ;Wang, CJ;Chao, YJ;Chiang, NJ;Wang, HC;Tung, HL;Liu, HC;Shan, YS |
| 國家衛生研究院 |
2022-06-22 |
Dosing pattern and early cumulative dose of liposomal irinotecan in metastatic pancreatic cancer: A real-world multicenter study
|
Su, YY;Chiang, NJ;Li, CP;Yen, CJ;Yang, SH;Chou, WC;Chen, JS;Chiu, TJ;Chen, YY;Chuang, SC;Bai, LY;Chiu, CF;Peng, CM;Chan, DC;Chiu, SC;Yang, YH;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2022-06-16 |
Cancer-cell-derived cell-free DNA can predict distant metastasis earlier in pancreatic cancer: A prospective cohort study
|
Huang, CJ;Huang, WY;Chen, CY;Chao, YJ;Chiang, NJ;Shan, YS |
| 國家衛生研究院 |
2022-06 |
Comparative genomic analysis and its prognostic impact on survival between viral hepatitis-related and non-viral hepatitis intrahepatic cholangiocarcinoma
|
Chiang, NJ;Tan, KT;Huang, CY;Chen, MH;Chiu, TJ;Shan, YS;Li, CF;Chen, LT |
| 國家衛生研究院 |
2022-05-15 |
Improved survival with induction chemotherapy and conversion surgery in locally advanced unresectable pancreatic cancer: A single institution experience
|
Su, YY;Ting, YL;Wang, CJ;Chao, YJ;Liao, TK;Su, PJ;Chiang, NJ;Liao, IC;Yu, YT;Liu, YS;Tsai, HM;Li, YJ;Huang, CJ;Liu, IT;Tsai, HJ;Yen, CJ;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2022-04-15 |
The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan
|
Yang, SH;Chiang, NJ;Chiu, SC;Chou, WC;Bai, LY;Li, CP;Su, YY;Chiu, TJ;Chuang, SC;Peng, CM;Chan, DC;Chen, JS;Yen, CJ;Chen, YY;Chiu, CF;Chen, LT;Shan, YS |
| 國家衛生研究院 |
2022-02-24 |
Semaphorin 6C suppresses proliferation of pancreatic cancer cells via inhibition of the AKT/GSK3/beta-catenin/cyclin D1 pathway
|
Hung, YH;Hsu, SH;Hou, YC;Chu, PY;Su, YY;Shan, YS;Hung, WC;Chen, LT |
| 國家衛生研究院 |
2022-02-19 |
Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin
|
Chiu, TJ;Yang, SH;Chiu, SC;Hsueh, SW;Chiang, NJ;Li, CP;Bai, LY;Cheng, FM;Chuang, SC;Shan, YS;Chan, DC;Chen, LT;Yen, CJ;Peng, CM;Su, YY;Chen, YY;Chen, JS;Chou, WC |
| 國家衛生研究院 |
2022-02-01 |
A prospective phase II study of biweekly S-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma
|
Bai, LY;Li, CP;Shan, YS;Chuang, SC;Chen, JS;Chiang, NJ;Chen, YY;Tsou, HH;Chuang, MH;Chiu, CF;Liu, TW;Chen, LT |
| 國家衛生研究院 |
2021-12-17 |
A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study
|
Su, YY;Chiu, YF;Li, CP;Yang, SH;Lin, J;Lin, SJ;Chang, PY;Chiang, NJ;Shan, YS;Ch’ang, HJ;Chen, LT |
| 國家衛生研究院 |
2021-11-30 |
Survival outcomes of management in metastatic gastric adenocarcinoma patients
|
Hu, HM;Tsai, HJ;Ku, HY;Lo, SS;Shan, YS;Chang, HC;Chao, Y;Chen, JS;Chen, SC;Chiang, CJ;Li, AF;Wang, HP;Wang, TE;Bai, LY;Wu, MS;Chen, LT;Liu, TW;Yang, YH |
| 國家衛生研究院 |
2021-11-20 |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study
|
Chiu, TJ;Su, YY;Yang, SH;Li, CP;Bai, LY;Chiang, NJ;Chuang, SC;Shan, YS;Chan, DC;Chen, LT;Yen, CJ;Peng, CM;Chen, YY;Chen, JS;Chou, WC |
| 國家衛生研究院 |
2021-11-12 |
The prognostic and predictive role of chromogranin a in gastroenteropancreatic neuroendocrine tumors - A single-center experience
|
Tsai, HJ;Hsiao, CF;Chang, JS;Chen, LT;Chao, YJ;Yen, CJ;Shan, YS |
| 國家衛生研究院 |
2021-11-01 |
Exfoliated tumor cells in bile as a promising indicator of disease status in cholangiocarcinoma
|
Gopinathan, P;Lu, TH;Chiang, NJ;Huang, CJ;Tu, HC;Hung, SC;Shan, YS;Lee, GB |
| 國家衛生研究院 |
2021-09 |
A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer
|
Chiang, NJ;Bai, LY;Huang, CJ;Chen, SC;Hsiao, CF;Shan, YS;Su, YY;Chen, L;Chen, MH |
| 國家衛生研究院 |
2021-07-15 |
No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol
|
Shan, YS;Chen, LT;Wu, CH;Chang, YF;Lee, CT;Chiang, NJ;Chao, YJ;Yen, CJ;Tsai, HJ;Huang, HE;Tsai, CR;Weng, YL;Yang, HC;Liu, HC;Chang, JS |
| 國家衛生研究院 |
2021-05 |
High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial
|
Pen, SL;Shan, YS;Hsiao, CF;Liu, TW;Chen, JS;Ho, CL;Chou, WC;Hsieh, RK;Chen, LT;Ch'ang, HJ |
| 國家衛生研究院 |
2021-05 |
TCOG T5217 trial: A phase II randomized study of SLOG versus modified FOLFIRINOX as the first-line treatment in locally advanced or metastatic pancreatic ductal adenocarcinoma
|
Chiang, NJ;Shan, YS;Bai, LY;Li, CP;Chen, JS;Yang, SH;Kuo, YC;Chao, Y;Hsieh, YY;Kao, HF;Hsiao, CF;Chen, LT |
| 國家衛生研究院 |
2021-04-12 |
An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan
|
Chang, JS;Chen, LT;Shan, YS;Chu, PY;Tsai, CR;Tsai, HJ |
| 國家衛生研究院 |
2021-03-26 |
A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer[Erratum:Gastric Cancer. 2021 Jan 29;Article in Press.]
|
Hsu, CC;Liao, WY;Chang, KY;Chan, TS;Huang, PJ;Chiang, CT;Shan, YS;Cheng, LH;Liao, TY;Tsai, KK |
| 國家衛生研究院 |
2021-01-29 |
A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer
|
Hsu, CC;Liao, WY;Chang, KY;Chan, TS;Huang, PJ;Chiang, CT;Shan, YS;Cheng, LH;Liao, TY;Tsai, KK |
| 國家衛生研究院 |
2021-01-13 |
Development of possible next line of systemic therapies for gemcitabine-resistant biliary tract cancers: A perspective from clinical trials
|
Chiang, NJ;Chen, LT;Shan, YS;Yeh, CN;Chen, MH |
| 中山醫學大學 |
2021 |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients' experience within a population-based study
|
Chiu, TJ; Su, YY; Yang, SH; Li, CP; Bai, LY; Chiang, NJ; Chuang, SC; Shan, YS; Chan, DC; Chen, LT; Yen, CJ; Peng, CM; Chen, YY; Chen, JS; Chou, WC |
| 國家衛生研究院 |
2020-11-13 |
The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort [Erraturm: Scientific Reports. 2020 May 4;10:Article number 7420.]
|
Su, YY;Chiang, NJ;Tsai, HJ;Yen, CJ;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2020-11-01 |
Aptamer probed isolation of circulating tumor cells in cholangiocarcinoma patients
|
Gopinathan, P;Chiang, NJ;Wang, CH;Sinha, A;Tsai, YC;Tu, HC;Hung, SC;Hsu, PH;Shan, YS;Lee, GB |
| 國家衛生研究院 |
2020-11 |
An integrated microfluidic platform for cholangiocarcinoma diagnosis from clinical bile juice samples by utilizing multiple affinity reagents
|
Lu, TH;Chiang, NJ;Huang, CJ;Gopinathan, P;Tu, HC;Tsai, YC;Shan, YS;Hung, SC;Lee, GB |
| 國家衛生研究院 |
2020-10-31 |
c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation
|
Chang, TM;Chu, PY;Hung, WC;Shan, YS;Lin, HY;Huang, KW;Chang, JS;Chen, LT;Tsai, HJ |
| 國家衛生研究院 |
2020-05-28 |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Chiang, NJ;Chen, MH;Yang, SH;Hsu, C;Yen, CJ;Tsou, HH;Su, YY;Chen, JS;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2020-05-26 |
Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan
|
Shan, YS;Chen, LT;Wu, JS;Chang, YF;Lee, CT;Wu, CH;Chiang, NJ;Huang, HE;Yen, CJ;Chao, YJ;Tsai, HJ;Chen, CY;Kang, JW;Kuo, CF;Tsai, CR;Weng, YL;Yang, HC;Liu, HC;Chang, JS |
| 國家衛生研究院 |
2020-05-04 |
The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort
|
Su, YY;Chiang, NJ;Tsai, HJ;Yen, CJ;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2020-05 |
Exploring Circulating Tumor Cells in cholangiocarcinoma using a novel glycosaminoglycan probe on a microfluidic platform
|
Gopinathan, P;Chiang, NJ;Bandaru, A;Sinha, A;Huang, WY;Hung, SC;Shan, YS;Lee, GB |
| 國家衛生研究院 |
2020-01 |
A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study
|
Chiang, NJ;Tsai, KK;Hsiao, CF;Yang, SH;Hsiao, HH;Shen, WC;Hsu, C;Lin, YL;Chen, JS;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2020-01 |
DUSP2 regulates extracellular vesicle-VEGF-C secretion and pancreatic cancer early dissemination
|
Wang, CA;Chang, IH;Hou, PC;Tai, YJ;Li, WN;Hsu, PL;Wu, SR;Chiu, WT;Li, CF;Shan, YS;Tsai, SJ |
| 國家衛生研究院 |
2019-12-18 |
An open-label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy of TLC388 and genomic analysis for poorly differentiated neuroendocrine carcinomas
|
Chen, MH;Chou, WC;Hsiao, CF;Jiang, SS;Tsai, HJ;Liu, YC;Hsu, C;Shan, YS;Hung, YP;Hsich, CH;Chiu, CH;Liu, TC;Cho, SF;Liu, TW;Chao, Y |
| 國家衛生研究院 |
2019-12-01 |
Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study
|
Bang, YJ;Li, CP;Lee, KH;Chiu, CF;Park, JO;Shan, YS;Kim, JS;Chen, JS;Shim, HJ;Rau, KM;Choi, HJ;Oh, DY;Belanger, B;Chen, LT |
| 國家衛生研究院 |
2019-09 |
Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8
|
Wang, HC;Lin, YL;Hsu, CC;Chao, YJ;Hou, YC;Chiu, TJ;Huang, PH;Tang, MJ;Chen, LT;Shan, YS |
| 國家衛生研究院 |
2019-08-29 |
The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis
|
Hsu, CC;Liao, WY;Chan, TS;Chen, WY;Lee, CT;Shan, YS;Huang, PJ;Hou, YC;Li, CR;Tsai, KK |
| 國家衛生研究院 |
2019-07-30 |
Nuclear KIT induces a NFKBIB-RELA-KIT autoregulatory loop in imatinib-resistant gastrointestinal stromal tumors
|
Hsueh, YS;Chang, HH;Shan, YS;Sun, HS;Fletcher, JA;Li, CF;Chen, LT |
| 國家衛生研究院 |
2019-07-26 |
The epidemiology of gastric cancers in the era of Helicobacter pylori eradication: A nation-wide cancer registry-based study in Taiwan
|
Chang, JS;Kuo, SH;Chu, PY;Shan, YS;Tsai, CR;Tsai, HJ;Chen, LT |
| 國家衛生研究院 |
2019-07 |
Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer
|
Hsu, MC;Tsai, YL;Lin, CH;Pan, MR;Shan, YS;Cheng, TY;Cheng, SHC;Chen, LT;Hung, WC |
| 國家衛生研究院 |
2019-05-20 |
Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer
|
Weng, CC;Hsieh, MJ;Wu, CC;Lin, YC;Shan, YS;Hung, WC;Chen, LT;Cheng, KH |
| 國家衛生研究院 |
2019-02 |
Mutational landscape by targeted next-generation sequencing in EBV-associated lymphoepithelioma-like cholangiocarcinoma
|
Chiang, NJ;Chen, MH;Chen, LT;Shan, YS |
| 國家衛生研究院 |
2019-01 |
Beta-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer
|
Kuo, TL;Cheng, KH;Shan, YS;Chen, LT;Hung, WC |
| 國家衛生研究院 |
2018-12-20 |
Protein arginine methyltransferase 3 enhances chemoresistance in pancreatic cancer by methylating hnRNPA1 to increase ABCG2 expression
|
Hsu, MC;Pan, MR;Chu, PY;Tsai, YL;Tsai, CH;Shan, YS;Chen, LT;Hung, WC |
| 國家衛生研究院 |
2018-12 |
c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation
|
Chang, TM;Shan, YS;Chu, PY;Lin, HY;Huang, KW;Hung, WC;Chen, LT;Tsai, HJ |
| 國家衛生研究院 |
2018-12 |
The epidemiology of gastric cancer in the era of H. pylori eradication: A nation-wide registry-based study in Taiwan
|
Tsai, HJ;Chang, JS;Shan, YS;Tsai, CR;Chen, LT |
| 國家衛生研究院 |
2018-11-07 |
Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial
|
Chen, LT;Siveke, JT;Wang-Gillam, A;Li, CP;Bodoky, G;Dean, AP;Shan, YS;Jameson, GS;Macarulla, T;Lee, KH;Cunningham, D;Blanc, JF;Chiu, CF;Schwartsmann, G;Braiteh, FS;Mamlouk, K;Belanger, B;de Jong, FA;Hubner, RA |
| 國家衛生研究院 |
2018-11 |
TCOG T1308 study: The final results of a phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer
|
Chiang, NJ;Chen, LT;Chen, JS;Yang, SH;Hsu, C;Shan, YS;Yen, CJ;Chen, MH;Tsou, HH |
| 國家衛生研究院 |
2018-10 |
Multicenter, phase II trial of biweekly S-1, leucovorin (LV), oxaliplatin and gemcitabine (SLOG) in metastatic pancreatic adenocarcinoma (mPDAC): Final report of TCOG T1211 study
|
Chiang, NJ;Tsai, KK;Chen, JS;Yang, SH;Hsiao, HH;Shan, YS;Chen, LT |
显示项目 31-80 / 133 (共3页)
1 2 3 > >>
每页显示[10|25|50]项目
|
